This study describes the treatment and survival of 54 patients with gross recurrent laryngeal carcinoma after radiotherapy. Twenty-six patients were treated with local ultra-high frequency hyperthermia in combination with radiotherapy and chemotherapy (HRCH). Twenty-eight control patients were treated with radiotherapy and chemotherapy (RCh). Eight patients (33 per cent) in HRCh showed a three year survival but no patient in the RCh group. At two years 18 patients (75 per cent) in HRCh and two (7 per cent) in RCh survived.
Национальный медицинский исследовательский центр онкологии, Ростов-на-Дону, Российская Федерация 2 Областной филиал Республиканского специализированного научно-практического медицинского центра онкологии и радиологии, Ташкент, Республика Узбекистан 3 центральный госпиталь Министерства внутренних дел, Ташкент, Республика Узбекистан adVanced paranasal cancer: clinical oBserVaTion svetitsky p. V. 1 , ganiev a. a. 2 , abdikhakimov a. n. 2 , ishmukhamedov s. n. 3 , Kit o. i. 1¹ national medical research centre for oncology, rostov-on-don, russian federation 2 regional Branch of republican specialized scientific-practical medical center of oncology and radiology, Tashkent, republic uzbekistan 3 hospital of ministry of internal affairs, Tashkent, republic uzbekistan
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.